A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia (NCT06238466)

🧪 Interventions in This Study

• AZD1705 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Research Site — Glendale, California
• Research Site — Jacksonville, Florida
• Research Site — Winter Park, Florida
• Research Site — Baltimore, Maryland
• Research Site — San Antonio, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cardiovascular

• The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting — Halifax, Nova Scotia
• Improving the Heart Health of Home Health Aides — New York, New York
• Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities — Birmingham, Alabama
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias — Hialeah, Florida

Explore by condition: All Cardiovascular clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.